IBDEI075 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2834,2)
 ;;=^5000547
 ;;^UTILITY(U,$J,358.3,2835,0)
 ;;=B17.10^^7^83^100
 ;;^UTILITY(U,$J,358.3,2835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2835,1,3,0)
 ;;=3^Hepatitis C, acute
 ;;^UTILITY(U,$J,358.3,2835,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,2835,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,2836,0)
 ;;=B18.2^^7^83^101
 ;;^UTILITY(U,$J,358.3,2836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2836,1,3,0)
 ;;=3^Hepatitis C, chronic without coma
 ;;^UTILITY(U,$J,358.3,2836,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,2836,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,2837,0)
 ;;=J11.1^^7^83^120
 ;;^UTILITY(U,$J,358.3,2837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2837,1,3,0)
 ;;=3^Influenza
 ;;^UTILITY(U,$J,358.3,2837,1,4,0)
 ;;=4^J11.1
 ;;^UTILITY(U,$J,358.3,2837,2)
 ;;=^5008158
 ;;^UTILITY(U,$J,358.3,2838,0)
 ;;=A92.30^^7^83^226
 ;;^UTILITY(U,$J,358.3,2838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2838,1,3,0)
 ;;=3^West Nile
 ;;^UTILITY(U,$J,358.3,2838,1,4,0)
 ;;=4^A92.30
 ;;^UTILITY(U,$J,358.3,2838,2)
 ;;=^5000443
 ;;^UTILITY(U,$J,358.3,2839,0)
 ;;=A49.8^^7^83^10
 ;;^UTILITY(U,$J,358.3,2839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2839,1,3,0)
 ;;=3^Acinetobacter
 ;;^UTILITY(U,$J,358.3,2839,1,4,0)
 ;;=4^A49.8
 ;;^UTILITY(U,$J,358.3,2839,2)
 ;;=^5000240
 ;;^UTILITY(U,$J,358.3,2840,0)
 ;;=A74.9^^7^83^36
 ;;^UTILITY(U,$J,358.3,2840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2840,1,3,0)
 ;;=3^Chlamydial
 ;;^UTILITY(U,$J,358.3,2840,1,4,0)
 ;;=4^A74.9
 ;;^UTILITY(U,$J,358.3,2840,2)
 ;;=^5000388
 ;;^UTILITY(U,$J,358.3,2841,0)
 ;;=A41.4^^7^83^187
 ;;^UTILITY(U,$J,358.3,2841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2841,1,3,0)
 ;;=3^Sepsis due to anaerobes
 ;;^UTILITY(U,$J,358.3,2841,1,4,0)
 ;;=4^A41.4
 ;;^UTILITY(U,$J,358.3,2841,2)
 ;;=^5000206
 ;;^UTILITY(U,$J,358.3,2842,0)
 ;;=B95.2^^7^83^71
 ;;^UTILITY(U,$J,358.3,2842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2842,1,3,0)
 ;;=3^Enterococcus spp.(other)
 ;;^UTILITY(U,$J,358.3,2842,1,4,0)
 ;;=4^B95.2
 ;;^UTILITY(U,$J,358.3,2842,2)
 ;;=^5000837
 ;;^UTILITY(U,$J,358.3,2843,0)
 ;;=A04.4^^7^83^75
 ;;^UTILITY(U,$J,358.3,2843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2843,1,3,0)
 ;;=3^Escherichia coli-intestinal
 ;;^UTILITY(U,$J,358.3,2843,1,4,0)
 ;;=4^A04.4
 ;;^UTILITY(U,$J,358.3,2843,2)
 ;;=^5000027
 ;;^UTILITY(U,$J,358.3,2844,0)
 ;;=B96.29^^7^83^74
 ;;^UTILITY(U,$J,358.3,2844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2844,1,3,0)
 ;;=3^Escherichia NEC
 ;;^UTILITY(U,$J,358.3,2844,1,4,0)
 ;;=4^B96.29
 ;;^UTILITY(U,$J,358.3,2844,2)
 ;;=^5000851
 ;;^UTILITY(U,$J,358.3,2845,0)
 ;;=A54.9^^7^83^91
 ;;^UTILITY(U,$J,358.3,2845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2845,1,3,0)
 ;;=3^Gonorrhea
 ;;^UTILITY(U,$J,358.3,2845,1,4,0)
 ;;=4^A54.9
 ;;^UTILITY(U,$J,358.3,2845,2)
 ;;=^5000336
 ;;^UTILITY(U,$J,358.3,2846,0)
 ;;=Z16.30^^7^83^119
 ;;^UTILITY(U,$J,358.3,2846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2846,1,3,0)
 ;;=3^Infection with drug-resistant organism
 ;;^UTILITY(U,$J,358.3,2846,1,4,0)
 ;;=4^Z16.30
 ;;^UTILITY(U,$J,358.3,2846,2)
 ;;=^5062737
 ;;^UTILITY(U,$J,358.3,2847,0)
 ;;=B96.1^^7^83^123
 ;;^UTILITY(U,$J,358.3,2847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2847,1,3,0)
 ;;=3^Klebsiella pneumoniae
 ;;^UTILITY(U,$J,358.3,2847,1,4,0)
 ;;=4^B96.1
 ;;^UTILITY(U,$J,358.3,2847,2)
 ;;=^5000846
 ;;^UTILITY(U,$J,358.3,2848,0)
 ;;=B96.4^^7^83^181
 ;;^UTILITY(U,$J,358.3,2848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2848,1,3,0)
 ;;=3^Proteus spp. (other)
 ;;^UTILITY(U,$J,358.3,2848,1,4,0)
 ;;=4^B96.4
 ;;^UTILITY(U,$J,358.3,2848,2)
 ;;=^5000853
 ;;
 ;;$END ROU IBDEI075
